United StatesBreaking News

The amount of inflation priced into 10-year Treasury yields is a little hard to square with what the market is saying about price rises in the near term. Either inflation is going to be high for a long time, and this is something that has changed in the past week or two, or 10-year yields have gone a little too far. Yelena Shulyatyeva, Senior US Economist at The Conference Board, discusses inflation expectations and what happens if oil prices rise higher, for longer.

A new era of elevated borrowing costs is potentially underway as war-driven inflation angst intensifies in the US bond market, sending 30-year yields toward a two-decade high above 5%. Guneet Dhingra, Head of US Rates Strategy at BNP Paribas, discusses the recent yield surge and why 5% may become the new 4%.

Design Therapeutics (NASDAQ:DSGN) announced positive biomarker and clinical findings from its ongoing Phase 1/2 RESTORE-FA clinical trial evaluating DT-216P2 in individuals with Friedreich ataxia (FA).

On this episode of Stock Movers with Alexis Christoforous: - NextEra Energy (NEE) agreed to pay about $67 billion in stock for Dominion Energy (D) in the biggest power acquisition ever, creating a giant utility extending from Florida to the data centers clustered in Virginia. The deal would give NextEra a swathe of electricity assets stretching across Virginia and the Carolinas. - Ryanair (RYAAY) gains as it delivered a decent end to the year, but flagged impact ahead from rising costs. The airline said unit costs for 2027 could increase by a mid-single digit percentage, with concerns over current unhedged jet fuel prices, and also impact from higher crew and aircraft maintenance costs. - Regeneron Pharmaceuticals (REGN) shares drop after the drugmaker's phase 3 data for fianlimab in metastatic melanoma fell short of expectations. Citi downgraded its rating on the stock following the "disappointing" trial update.

Brady Corporation (NYSE:BRC) reported its financial results for the fiscal 2026 third quarter ended April 30, 2026, delivering substantial top-line acceleration and record-setting profitability metrics.

AstraZeneca (NASDAQ:AZN) announced that the U.S. Food and Drug Administration (FDA) has approved BAXFENDY™ (baxdrostat) for the treatment of hypertension in adults.

Ramaco CEO Randall Atkins joined Bloomberg Open Interest to explain why China's steel dumping has hurt coal markets, why the company is betting big on rare earth minerals, and why processing, and not necessarily mining, is the toughest hurdle in building a US rare earth supply chain that's independent of China.

Nvidia is expected to set another revenue record when it reports quarterly earnings on Wednesday. Investors are looking for updates on its $1 trillion data-center revenue target. Bloomberg's Caroline Hyde has a preview.

WeTouch Technology (NASDAQ:WETH) reported its unaudited financial results for the first quarter ended March 31, 2026, delivering significant bottom-line acceleration and stable revenue growth.

NextEra Energy (NYSE:NEE) announced Monday a definitive agreement to acquire Dominion Energy (NYSE:D) in an all-stock transaction valued at approximately $67 billion.

Joe Kaiser, the CEO of Switchyard Partners, joined Bloomberg Open Interest to explain why the massive NextEra, Dominion merger is really about powering the AI boom. He breaks down how hyperscale data centers are reshaping the US energy grid, why regulators will likely approve the deal, and why renewable energy plus natural gas will define the next era of AI infrastructure.

NextEra Energy agreed to pay about $67 billion in stock for Dominion Energy in the biggest power acquisition ever. Bloomberg's Emily Forgash reports on "Bloomberg Open Interest."